Lanean...
Therapeutic Potential of Lebrikizumab in the Treatment of Atopic Dermatitis
BACKGROUND: Atopic dermatitis (AD) is a chronic, relapsing skin condition with a wide disease spectrum. Moderate-to-severe cases often need systemic treatment. Conventional immunosuppressants have extensive side effect profiles and require close monitoring. In recent decades, there has been increasi...
Gorde:
| Argitaratua izan da: | J Asthma Allergy |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7023853/ https://ncbi.nlm.nih.gov/pubmed/32104006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S211032 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|